Eargo Inc. Stock News

Eargo (EAR) stock is rocketing higher on Thursday thanks to news from the DOJ concerning an investigation into the company.

The shares of micro-cap medical device company, Eargo (EAR), have climbed ~76.8% in the pre-market after disclosing that a criminal investigation initiated by the U.S

Eargo (EAR) stock is rocketing higher on Thursday thanks to news from the DOJ concerning an investigation into the company. The post EAR Stock: The DOJ News That Has Eargo Investors Hearing ‘Cha-Chi

Sixth-Generation Device Automatically Adapts to All Environments for an Enhanced Hearing Experience Sixth-Generation Device Automatically Adapts to All Environments for an Enhanced Hearing Experience

Parametric Portfolio Associates LLC bought a new stake in shares of Eargo, Inc. (NASDAQ:EAR) in the second quarter, HoldingsChannel.com reports. The firm bought 5,357 shares of the companys stock, valued at approximately $214,000. A number of other institutional investors and hedge funds also recently made changes to their positions in EAR. BlackRock Inc. grew its []

NEW YORK, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Bristol-Myers Squibb Company (NYSE: BMY)

Eargo Inc. (NASDAQ:EAR) traded at $4.83 at close of the session on Tuesday, 12/21/21, made an upward move of 5.00% on its previous days price. Looking at the stock we see that its previous close was $4.60 with the days price range being $4.60 $4.9401. In terms of its 52-week price range, EAR has Eargo Inc. (NASDAQ: EAR) Is A Buzzing Hot Stock Read More »

Inogen and Eargo are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability

Inogen (NASDAQ:INGN) and Eargo (NASDAQ:EAR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations and institutional ownership. Analyst Ratings This is a summary of recent recommendations and price targets for Inogen and Eargo, as [] The post Comparing Inogen (NASDAQ:INGN) & Eargo (NASDAQ:EAR) appeared first on ETF Daily News .

Eargo Inc. (NASDAQ:EAR) price on Thursday, December 09, fall -4.26% below its previous days close as a downside momentum from buyers pushed the stocks value to $5.39. A look at the stocks price movement, the close in the last trading session was $5.63, moving within a range at $5.1301 and $5.72. Turning to its 52-week Thinking Of Buying Eargo Inc. (NASDAQ: EAR) Stock? Heres What You Need To Know Read More »

Phreesia (PHR) delivered earnings and revenue surprises of -51.06% and 15.19%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock?

Avid Bioservices (CDMO) delivered earnings and revenue surprises of 400% and 4.44%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock?

(PR-inside.com) NEW ORLEANS, LA / ACCESSWIRE / December 5, 2021 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 6, 2021 to file lead plaintiff applications in securities class action lawsuits against Eargo, Inc. (NasdaqGS:EAR), if they purchased the Company''s shares in the expanded period between October 15, 2020 and September 22, 2021, inclusive (the "Class Period") and/or pursuant to the Company''s October 2020 initial public offering (the "IPO"). These actions are pending in the United States District Court for the Northern District ..

(PR-inside.com) SAN FRANCISCO, CA / ACCESSWIRE / December 5, 2021 / Hagens Berman urges Eargo, Inc. (NASDAQ: EAR) investors with losses in excess of $500,000 to submit your losses now. Class Period: Oct. 15, 2020 - Sept. 22, 2021 Lead Plaintiff Deadline: Dec. 6, 2021 Visit: www.hbsslaw.com/cases/EAR Contact An Attorney Now: [email protected] 844-916-0895 Eargo, Inc. (EAR) Securities Fraud Class Action: Eargo, a hearing aid manufacturer, targets consumers with hearing aid insurance, and provides insurance claims processing for these customers. Consequently, a significant portion of Eargo''s accounts receivables is insurance reimbursement claims the Company has submitted to government-sponsored healthcare and private insurance. The complaint alleges that Defendants misled investors between ..